Major determinants of hyperhomocysteinemia in peritoneal dialysis patients
- 1 June 1998
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 53 (6), 1775-1782
- https://doi.org/10.1046/j.1523-1755.1998.00918.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patientsKidney International, 1997
- Hyperhomocysteinemia Confers an Independent Increased Risk of Atherosclerosis in End-Stage Renal Disease and Is Closely Linked to Plasma Folate and Pyridoxine ConcentrationsCell Metabolism, 1996
- Homocysteine and Risk of Premature Coronary Heart DiseaseCirculation, 1996
- Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patientsAtherosclerosis, 1996
- Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine ConcentrationsCell Metabolism, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Accumulation of Sulphur-Containing Amino Acids Including Cysteine-Homocysteine in Patients on Maintenance HaemodialysisClinical Science, 1980
- Plasma amino acid abnormalities in chronic renal failureClinica Chimica Acta; International Journal of Clinical Chemistry, 1972